Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 191

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 191
---
 treated as the “acquired” company and ONE Nuclear will be treated as the accounting acquirer for financial statement reporting purposes. Accordingly, the Business Combination will be treated as the equivalent of ONE Nuclear issuing stock for the net assets of HVII, accompanied by a recapitalization. The net assets of HVII will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination will be those of ONE Nuclear.

ONE Nuclear has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances under both the No Redemption Scenario and the Maximum Redemptions Scenario:

| ● | The equity holders of ONE Nuclear will have the greatest voting interest in the New ONE Nuclear; |
| ● | The equity holders of ONE Nuclear will have the ability to control decisions regarding election  
 and removal of directors and officers of the New ONE Nuclear;                                    |
| ● | ONE Nuclear will comprise the ongoing operations of the New ONE Nuclear; and                     |
| ● | ONE Nuclear’s existing senior management will be the senior management of the New ONE Nuclear.   |

Regulatory Matters

Neither HVII nor ONE Nuclear are aware of any material regulatory approvals or actions that are required for completion of the Business Combination, other than the filing required by and the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the other regulatory notices and approvals discussed in the section of this proxy statement/prospectus entitled “ The Business Combination Agreement —Conditions to Closing; Termination — Conditions to Closing — Mutual Conditions.” The parties have not yet made the filing required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976. It is presently contemplated that if any such additional regulatory approvals or actions are required, those approvals or actions will be sought. There can be no assurance, however, that any additional approvals or actions will be obtained.

| 129 |

<div align='center'>THE BUSINESS COMBINATION AGREEMENT</div>

The following is a summary of the material terms of the Business Combination Agreement. A copy of the Business Combination Agreement is attached as Annex A to this proxy statement/prospectus and is incorporated by reference into this proxy statement/prospectus. The Business Combination Agreement has been attached to this proxy statement/prospectus to provide you with information regarding its terms. It is not intended to provide any other factual information about HVII, Merger Sub or ONE Nuclear. The following description does not purport to be complete and is qualified in its entirety